NKGEN BIOTECH INC (NKGN)
- Market Cap
- $1M
About NKGEN BIOTECH INC
NKGEN BIOTECH INC
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1 institution reported holding NKGN, with 2.8 million shares worth $165.4 million in aggregate. The largest reported holder was Meteora Capital, with 2.8 million shares worth $165.4 million. Of the 1 largest holders listed below, 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Meteora Capital | 2,755,935 | $165M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
Who are the largest institutional holders of NKGN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of NKGN were Meteora Capital.
How many institutions own NKGN?
1 institution reported a position in NKGN for the quarter ended June 30, 2026, worth $165.4 million in total.
Did institutions buy or sell NKGN last quarter?
Of the 1 largest reported holders, 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for NKGN.
Every reported institutional holder, plus insider and congressional trades in NKGN, on SentiSense.